BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38359345)

  • 1. Pulmonary Thrombotic Complication of Mycoplasma pneumoniae Pneumonia in Chinese Children: Clinical Feature and Risk Factor Analysis.
    Yu Y; Jin X; Zhang X; Shen Y
    Pediatr Infect Dis J; 2024 Jun; 43(6):505-510. PubMed ID: 38359345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycoplasma pneumoniae pneumonia associated thrombosis at Beijing Children's hospital.
    Liu J; He R; Wu R; Wang B; Xu H; Zhang Y; Li H; Zhao S
    BMC Infect Dis; 2020 Jan; 20(1):51. PubMed ID: 31948402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. D-dimer: The Risk Factor of Children's Severe Mycoplasma Pneumoniae Pneumonia.
    Qiu J; Ge J; Cao L
    Front Pediatr; 2022; 10():828437. PubMed ID: 35498793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of D-dimer levels in refractory Mycoplasma pneumoniae pneumonia.
    Huang X; Li D; Liu F; Zhao D; Zhu Y; Tang H
    BMC Infect Dis; 2021 Jan; 21(1):14. PubMed ID: 33407216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identify clinical factors related to Mycoplasma pneumoniae pneumonia with hypoxia in children.
    Ling Y; Zhang T; Guo W; Zhu Z; Tian J; Cai C; Xu Y
    BMC Infect Dis; 2020 Jul; 20(1):534. PubMed ID: 32698769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study of general and severe mycoplasma pneumoniae pneumonia in children.
    Yang S; Lu S; Guo Y; Luan W; Liu J; Wang L
    BMC Infect Dis; 2024 Apr; 24(1):449. PubMed ID: 38671341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features of severe Mycoplasma pneumoniae pneumonia with pulmonary complications in childhood: A retrospective study.
    Luo XQ; Luo J; Wang CJ; Luo ZX; Tian DY; Xie XH
    Pediatr Pulmonol; 2023 Oct; 58(10):2815-2822. PubMed ID: 37431970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Level of D-Dimer Is Positively Correlated With the Severity of
    Zheng Y; Hua L; Zhao Q; Li M; Huang M; Zhou Y; Wang Y; Chen Z; Zhang Y
    Front Cell Infect Microbiol; 2021; 11():687391. PubMed ID: 34336714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The epidemiology of paediatric Mycoplasma pneumoniae pneumonia in North China: 2006 to 2016.
    Gao LW; Yin J; Hu YH; Liu XY; Feng XL; He JX; Liu J; Guo Y; Xu BP; Shen KL
    Epidemiol Infect; 2019 Jan; 147():e192. PubMed ID: 31364532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical characteristics and risk factors for necrotizing pneumonia caused by Mycoplasma pneumoniae in children.
    Zheng B; Zhao J; Cao L
    BMC Infect Dis; 2020 Jun; 20(1):391. PubMed ID: 32487034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction Model for Severe Mycoplasma pneumoniae Pneumonia in Pediatric Patients by Admission Laboratory Indicators.
    Chang Q; Chen HL; Wu NS; Gao YM; Yu R; Zhu WM
    J Trop Pediatr; 2022 Jun; 68(4):. PubMed ID: 35903920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new dynamic nomogram for predicting the risk of severe Mycoplasma pneumoniae pneumonia in children.
    Zhang X; Sun R; Jia W; Li P; Song C
    Sci Rep; 2024 Apr; 14(1):8260. PubMed ID: 38589453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The combination of initial markers to predict refractory Mycoplasma pneumoniae pneumonia in Chinese children: a case control study.
    Wen J; Su Y; Sun H; Zhang H; Li H
    Respir Res; 2021 Mar; 22(1):89. PubMed ID: 33752670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization strategy for the early timing of bronchoalveolar lavage treatment for children with severe mycoplasma pneumoniae pneumonia.
    Wu X; Lu W; Wang T; Xiao A; Guo X; Xu Y; Li S; Liu X; Zeng H; He S; Zhang X
    BMC Infect Dis; 2023 Oct; 23(1):661. PubMed ID: 37798699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics and serum inflammatory markers of community-acquired mycoplasma pneumonia in children.
    Fan F; Lv J; Yang Q; Jiang F
    Clin Respir J; 2023 Jul; 17(7):607-617. PubMed ID: 37142438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of risk factors of bronchial mucus plugs in children with Mycoplasma pneumoniae pneumonia.
    Zhang J; Wang T; Li R; Ji W; Yan Y; Sun Z; Tan J; Wu J; Huang L; Chen Z
    BMC Infect Dis; 2021 Jan; 21(1):67. PubMed ID: 33441105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early predictors of delayed radiographic resolution of lobar pneumonia caused by Mycoplasma pneumoniae in children: a retrospective study in China.
    Zheng Y; Mao G; Dai H; Li G; Liu L; Chen X; Zhu Y
    BMC Infect Dis; 2024 Apr; 24(1):414. PubMed ID: 38641804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Childhood
    Wang F; Cheng Q; Duo H; Wang J; Yang J; Jing S; Li J; Zhou X; Shang Y; Chen N; Tian Z; Zhang H; Cai X
    Microbiol Spectr; 2024 May; 12(5):e0009724. PubMed ID: 38606996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis of the Clinical Efficacy and Safety of High- and Low-dose Methylprednisolone in the Treatment of Children With Severe Mycoplasma Pneumoniae Pneumonia.
    Sun LL; Ye C; Zhou YL; Zuo SR; Deng ZZ; Wang CJ
    Pediatr Infect Dis J; 2020 Mar; 39(3):177-183. PubMed ID: 31738328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in coagulation markers in children with Mycoplasma pneumoniae pneumonia and their predictive value for Mycoplasma severity.
    Li YT; Zhang J; Wang MZ; Ma YM; Zhi K; Dai FL; Li SJ
    Ital J Pediatr; 2023 Oct; 49(1):143. PubMed ID: 37858230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.